These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 19006500)

  • 1. Analysis of yellow fever vaccination practice in England.
    Bryant N; Tucker R; Simons H; Bailey S; Mathewson J; Lea G; Hill DR
    J Travel Med; 2008; 15(5):287-93. PubMed ID: 19006500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of travel medicine practice by yellow fever vaccination centers in England, Wales, and Northern Ireland.
    Boddington NL; Simons H; Launders N; Gawthrop M; Stillwell A; Wong C; Mathewson J; Hill DR
    J Travel Med; 2012; 19(2):84-91. PubMed ID: 22414032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality improvement in travel medicine: a programme for yellow fever vaccination centres in England, Wales and Northern Ireland.
    Boddington NL; Simons H; Launders N; Hill DR
    Qual Prim Care; 2011; 19(6):391-8. PubMed ID: 22340901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quality of travel clinics in the Netherlands.
    Moerland W; Koeman SC; van den Hoek A; Warris-Versteegen AA; Inspector H; Overbosch D; Sonder GJ
    J Travel Med; 2006; 13(6):356-60. PubMed ID: 17107429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of yellow fever vaccination centers in Canada.
    Labelle C; Macpherson DW
    J Travel Med; 2005; 12(4):180-3. PubMed ID: 16086891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standards of yellow fever vaccination and travel medicine practice in the Republic of Ireland: A questionnaire-based evaluation.
    Noone P; Hamza M; Tang J; Flaherty G
    Travel Med Infect Dis; 2015; 13(5):409-14. PubMed ID: 26148651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand.
    O'Brien B; Leggat PA
    Travel Med Infect Dis; 2010 Jul; 8(4):210-2. PubMed ID: 20970723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists and travel advice for tropics in Lisbon (Portugal).
    Teodósio R; Gonçalves L; Imperatori E; Atouguia J
    J Travel Med; 2006; 13(5):281-7. PubMed ID: 16987127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late vaccination against yellow fever of travelers visiting endemic countries.
    Krief I; Goldblatt JG; Paz A; Potasman I
    Travel Med Infect Dis; 2006 Mar; 4(2):94-8. PubMed ID: 16887731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of travel health advice in a French travel medicine and vaccine center: a prospective observational study.
    Bouldouyre MA; De Verdière NC; Pavie J; De Castro N; Ponscarme D; Hamane S; Rachline A; Ferret S; Molina JM
    J Travel Med; 2012; 19(2):76-83. PubMed ID: 22414031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing standard pretravel health advice--a study in Belgium.
    Van De Winkel K; Van den Daele A; Van Gompel A; Van den Ende J
    J Travel Med; 2007; 14(5):288-96. PubMed ID: 17883459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness of rabies risks and knowledge about preventive measures among experienced German travel health advisors.
    Ross RS; Wolters B; Viazov SO; Roggendorf M
    J Travel Med; 2006; 13(5):261-7. PubMed ID: 16987124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention.
    Lopez-Velez R; Bayas JM
    J Travel Med; 2007; 14(5):297-305. PubMed ID: 17883460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yellow fever vaccines and international travelers.
    Barnett ED; Wilder-Smith A; Wilson ME
    Expert Rev Vaccines; 2008 Jul; 7(5):579-87. PubMed ID: 18564013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Yellow fever: new recommendations].
    Rochat L; Genton B
    Rev Med Suisse; 2014 May; 10(429):1014-9. PubMed ID: 24908746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferences and decision needs of Boston-area travelers to countries with risk of Yellow fever virus transmission: implications for health care providers.
    Lown BA; Chen LH; Han PV; Jentes ES; Wilson ME; Benoit CM; Avery KA; Ooi W; Hamer DH; Barnett ED;
    J Travel Med; 2014; 21(4):266-71. PubMed ID: 24734961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advice on malaria and yellow fever prevention provided at travel agencies in Cuzco, Peru.
    Villanueva-Meyer PG; Garcia-Jasso CA; Springer CA; Lane JK; Su BS; Hidalgo IS; Goodrich MR; Deichsel EL; White AC; Cabada MM
    J Travel Med; 2015; 22(1):26-30. PubMed ID: 25156197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow fever recommendations for tourists to Kenya: a flawed risk assessment?
    Behrens RH
    J Travel Med; 2008; 15(5):285-6. PubMed ID: 19006499
    [No Abstract]   [Full Text] [Related]  

  • 20. The US-Certified Yellow Fever Vaccination Center Registry: a tool for travelers, state health departments, and vaccine providers.
    Russell MN; Cetron MS; Eidex RB
    J Travel Med; 2006; 13(1):48-9. PubMed ID: 16412108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.